Last reviewed · How we verify
NCT03443284
Health Partner Evaluation at Providence
NA trial testing Health Partner in Total Knee Arthroplasty; Total Hip Arthroplasty in 79 participants. Terminated before completion.
17 December 2019
Quick facts
| Lead sponsor | DePuy Orthopaedics |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 79 |
| Start date | 11 December 2018 |
| Primary completion | 17 December 2019 |
| Estimated completion | 17 December 2019 |
| Sites | 3 locations across United States |
Drugs / interventions tested
- Health Partner
- Standard Care — full drug profile →
Conditions studied
- Total Knee Arthroplasty; Total Hip Arthroplasty — all drugs for Total Knee Arthroplasty; Total Hip Arthroplasty →
Sponsor
DePuy Orthopaedics — full company profile →
Who can join
18 and older, any sex, with Total Knee Arthroplasty; Total Hip Arthroplasty. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective, mixed methods, multi-center, randomized, comparative, controlled study. Providence Health \& Services will enroll a total of 296 subjects (18 years or older) who are electing to have total knee or hip replacement surgery. Subjects will be randomized to either the treatment group (Health Partner alongside standard care) or the control group (standard care alone). Health Partner is a combination of an iPhone or iPod Touch Operating System mobile application and a health care provider portal. The primary objective is to compare care plan adherence (pre- and post-surgery) for Health Partner vs. control subjects. Secondary objectives include evaluating all-cause medical resource utilization, communication with health care provider, well-being, fear of surgery, confidence in recovery from surgery, sleep, and patient satisfaction for 90 days post-surgery. To evaluate the behavioral factors associated with care path adherence using a qualitative interview method.To evaluate the usability and preferences of patients in their interaction with the intervention using a qualitative interview method, for product development. The total planned study duration is approximately 1 year and 7 months.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03443284
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Health Partner
Trials testing the same drug.
- NCT03386786 — Health Partner Evaluation at Princeton · NA · terminated
Other DePuy Orthopaedics trials
Trials by the same sponsor.
- NCT06631638 — EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN)) · NA · recruiting
- NCT06323980 — INHANCE Stemless Reverse Shoulder IDE · NA · recruiting
- NCT05357664 — PINNACLE® DM RSA Study · NA · terminated
- NCT04630262 — ATTUNE Cementless FB Tibial Base Clinical Study · NA · terminated
- NCT04730271 — Comparison of Alignment Achieved Using the VELYS Robotic-Assisted Solution Versus Manual Instrumentation in Total Knee A · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03443284 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by DePuy Orthopaedics
- Last refreshed: 2 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03443284.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing